Microrna biomarkers for multi cancer early detection test (mced)
AssigneeUniversity of Southampton
InventorsAndrew George SHAPANIS, Paul James Stuart SKIPP
Life of this patent
Estimating the term…
Abstract
The invention relates to a method of diagnosing a cancer in a subject, wherein the method comprises determining the expression level of a set of miRNAs in a sample obtained from the subject. The invention also relates to a method of identifying the site of localisation of a cancer in a subject. The invention also provides method of treating a subject with cancer.
Claims25
A method of diagnosing a cancer in a subject, wherein the method comprises:
- i. providing a biological sample obtained from the subject;
- ii. determining the expression level of at least three miRNAs in the sample obtained from the subject;
- iii. using the results from (ii) to determine if the subject has a cancer.
A method of determining the localisation of a cancer in a subject, comprising:
- i. providing a biological sample obtained from the subject;
- ii. determining the expression level of a panel of miRNAs, the panel comprising miRNAs having the sequences of at least three of, up to all of, SEQ ID NOs 1-50, in the sample obtained from the subject;
- and
- iii. using the results from (ii) to determine a location of the cancer, optionally wherein a second machine learning model is used to identify the location of the cancer in the event that the first machine learning model determines that the subject has cancer, optionally wherein the second machine learning model comprises a feedforward artificial neural network.
The method of any preceding claim, wherein the biological sample is a biological fluid, such as a blood, plasma, serum, urine or cerebrospinal fluid sample.
The method of any preceding claim, wherein the cancer is a solid cancer, optionally wherein the solid cancer is selected from the group consisting of:
- bladder cancer, bone and soft tissue sarcoma, breast cancer, colorectal cancer, oesophageal cancer, gastric cancer, glioblastoma, hepatocellular carcinoma (HCC), lung cancer, ovarian cancer, pancreatic cancer, or prostate cancer.
The method of any preceding claim, wherein the cancer is stage 0 cancer, stage 1 cancer, stage 2 cancer, stage 3 cancer or stage 4 cancer
A method of treating a subject with cancer, wherein the method comprises:
- i. providing a biological sample obtained from the subject;
- ii. determining the expression level of at least three miRNAs in the sample obtained from the subject;
- iii. using the results from (ii) to determine if the subject has a cancer;
- and
- iv. administering an anti-cancer therapeutic to the subject if the subject is determined to have cancer.
The kit of claim 24, wherein the reagents are one or more oligonucleotide primers specific for each of the at least three miRNAs.
Dependencies are inferred from the claim text.